Related Experiment Video
Updated: Jun 11, 2025

07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
175
SCancerRNA: Expression at the Single-cell Level and Interaction Resource of Non-coding RNA Biomarkers for Cancers.
Hongzhe Guo1, Liyuan Zhang1, Xinran Cui1
1Faculty of Computing, Harbin Institute of Technology, Harbin 150001, China.
Genomics, Proteomics & Bioinformatics
|September 28, 2024
Summary
A new database, SCancerRNA, offers insights into non-coding RNA biomarkers in cancer. It details their expression in single cells, aiding cancer diagnosis and therapy development.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Non-coding RNAs (ncRNAs) are crucial in cancer, acting as tumor suppressors or oncogenes.
- ncRNAs' stability in bodily fluids makes them promising biomarkers for early cancer detection.
- Understanding cell-specific gene expression is vital due to tumor heterogeneity.
Purpose of the Study:
- To create a comprehensive online resource for ncRNA biomarkers in cancer.
- To provide single-cell level expression data for various ncRNA types.
- To link biomarkers with their functions and clinical applications.
Main Methods:
- Compiled experimentally supported data on long ncRNAs, microRNAs, PIWI-interacting RNAs, small nucleolar RNAs, and circular RNAs.
- Focused on differential expression analysis at the single-cell level.
- Integrated information on biological functions and clinical relevance.
Main Results:
- Developed the SCancerRNA database, a centralized resource for ncRNA biomarker data.
- Included data on expression patterns across different cell types in cancers.
- Summarized clinical applications for diagnosis, progression monitoring, and targeted therapies.
Conclusions:
- SCancerRNA facilitates the use of ncRNA biomarkers for cancer management.
- The database supports research into ncRNA interactions and computational modeling.
- Provides a valuable tool for advancing cancer diagnostics and therapeutics.

